# Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a

> **NCT00508040** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 58 (actual)

## Conditions studied

- Birdshot Chorioretinopathy
- Cystoid Macular Edema
- Transient Partial Visual Loss

## Interventions

- **DRUG:** interferon alpha 2a
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00508040
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-10
- **Final completion:** 2013-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2013-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00508040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00508040, "Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00508040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*